• WKN: A1EMG5
  • ISIN: DE000A1EMG56
  • Land: Deutschland

Nachricht vom 14.12.2020 | 16:04


SPORTTOTAL AG / Key word(s): Personnel

14-Dec-2020 / 16:04 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

SPORTTOTAL AG announces Supervisory Board membership change

- Dr. Michael Kern and Jens Reidel to stand down from the Supervisory Board

- Christoph Tönsgerlemann and Martin Ott to be proposed for membership

Cologne, December 14, 2020. Supervisory Board Chairman Dr. Michael Kern (65) and Mr. Jens Reidel (69) have today notified the Management Board of SPORTTOTAL AG that they wish to stand down from the Supervisory Board effective December 31, 2020. According to the departing Supervisory Board members, the background lies in the progressive digitization of SPORTTOTAL AG which should be overseen by a younger Supervisory Board.

The Management Board of SPORTTOTAL AG intends by agreement with the remaining member of the SPORTTOTAL AG Supervisory Board, Mr. Ralf Reichert (46), to apply to the competent Registry Court to appoint Mr. Christoph Tönsgerlemann (49), Chairman of the Management Board of ETL AG Wirtschaftsprüfungsgesellschaft Steuerberatungsgesellschaft and Mr. Martin Ott (45), Vice President, M&A and Corporate Ventures and Managing Director, adidas Ventures B.V., as members of the Supervisory Board.

Both Dr. Michael Kern and Mr. Jens Reidel are agreed in stating their intention to retain links with SPORTTOTAL AG as shareholders. The Management Board, and Ralf Reichert, would like to expressly thank both gentlemen for their long-standing commitment to their posts as members of the Supervisory Board of SPORTTOTAL AG.

Am Coloneum 2
50829 Cologne
Tel: +49 (0) 221_7 88 77_ 0
Fax: +49 (0) 221_7 88 77_ 199

Investor Relations
BSK Becker+Schreiner Kommunikation GmbH
Tobias M. Weitzel
Tel: +49 (0) 177_7 21 57 60

14-Dec-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie


Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021